Standard Biotools Stock Options

LAB Stock  USD 1.23  0.02  1.60%   
Standard Biotools' latest option contracts expiring on September 19th 2025 are carrying combined implied volatility of 2.74. The Standard Biotools option chain provides detailed quote and price information for the current Standard Biotools option contracts. It shows all of Standard Biotools' listed puts, calls, expiration dates, strike prices, and other pricing information.

In The Money vs. Out of Money Option Contracts on Standard Biotools

Analyzing Standard Biotools' in-the-money options over time can help investors to take a profitable long position in Standard Biotools regardless of its overall volatility. This is especially true when Standard Biotools' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Standard Biotools' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Standard Biotools' stock while costing only a fraction of its price.
Standard Biotools' stock options are financial instruments that give investors the right to buy or sell shares of Standard Biotools common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Standard stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Standard Biotools' stock price goes up or down, the stock options follow.
At present, Standard Biotools' Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock Shares Outstanding is expected to grow to about 370.9 M, whereas Common Stock Total Equity is forecasted to decline to about 64 K.

Standard Biotools In The Money Call Balance

When Standard Biotools' strike price is surpassing the current stock price, the option contract against Standard Biotools stock is said to be in the money. When it comes to buying Standard Biotools' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Standard Biotools are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Standard Current Options Market Mood

Standard Biotools' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Standard Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Volume

Unfortunately, most Standard Biotools' options investors are not very successful. Standard Biotools' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.

Rule 16 of the current Standard contract

Base on the Rule 16, the options market is currently suggesting that Standard Biotools will have an average daily up or down price movement of about 0.17% per day over the life of the 2025-09-19 option contract. With Standard Biotools trading at USD 1.23, that is roughly USD 0.002106. If you think that the market is fully incorporating Standard Biotools' daily price movement you should consider buying Standard Biotools options at the current volatility level of 2.74%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Purchasing Standard Biotools options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Standard calls. Remember, the seller must deliver Standard Biotools stock to the call owner when a call is exercised.

Standard Biotools Option Chain

When Standard Biotools' strike price is surpassing the current stock price, the option contract against Standard Biotools stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Standard Biotools' option chain is a display of a range of information that helps investors for ways to trade options on Standard. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Standard. It also shows strike prices and maturity days for a Standard Biotools against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntStrike PriceCurrent SpreadLast Price
Call
LAB250919C0000750007.50.0 - 0.750.75Out
Call
LAB250919C0000500005.00.0 - 0.750.75Out
Call
LAB250919C0000250002.50.0 - 0.750.75Out
Call
LAB250919C0000200002.00.0 - 0.750.75Out
Call
LAB250919C0000150001.50.0 - 0.650.65Out
Call
LAB250919C0000100001.00.0 - 0.350.35In
Call
LAB250919C0000050000.50.0 - 0.80.8In
 Put
LAB250919P0000050000.50.0 - 0.750.75Out
 Put
LAB250919P0000100001.00.0 - 0.40.4Out
 Put
LAB250919P0000150001.50.1 - 0.50.1In
 Put
LAB250919P0000200002.00.55 - 0.90.55In
 Put
LAB250919P0000250002.51.0 - 1.451.0In
 Put
LAB250919P0000500005.03.5 - 3.93.5In
 Put
LAB250919P0000750007.56.2 - 6.46.2In

Standard Biotools Market Cap Over Time

   Market Cap   
       Timeline  

Standard Total Stockholder Equity

Total Stockholder Equity

495.31 Million

At present, Standard Biotools' Total Stockholder Equity is projected to increase significantly based on the last few years of reporting.

Standard Biotools Corporate Management

Jeffrey BlackChief OfficerProfile
Shane BowenChief OfficerProfile
Elizabeth JensenChief OfficerProfile
Mark SpearmanSr CommunicationsProfile
Mike MusgnugSenior OfficerProfile
John GrazianoVice RelationsProfile
When determining whether Standard Biotools offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Standard Biotools' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Standard Biotools Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Standard Biotools Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Standard Biotools. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For information on how to trade Standard Stock refer to our How to Trade Standard Stock guide.
You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Standard Biotools. If investors know Standard will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Standard Biotools listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.32)
Revenue Per Share
0.453
Quarterly Revenue Growth
(0.14)
Return On Assets
(0.12)
Return On Equity
(0.26)
The market value of Standard Biotools is measured differently than its book value, which is the value of Standard that is recorded on the company's balance sheet. Investors also form their own opinion of Standard Biotools' value that differs from its market value or its book value, called intrinsic value, which is Standard Biotools' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Standard Biotools' market value can be influenced by many factors that don't directly affect Standard Biotools' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Standard Biotools' value and its price as these two are different measures arrived at by different means. Investors typically determine if Standard Biotools is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Standard Biotools' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.